Somatic mutations in the thyrotropin receptor gene and not in the G(s)α protein gene in 31 toxic thyroid nodules

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3885-3891

  Führer, Dagmar ^a   Holzapfel, Hans Peter ^a   Wonerow, Peter ^a   Scherbaum, Werner A ^a   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CODON; EXON; GENE FREQUENCY; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; NODULAR GOITER; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

BUTEA; FABACEAE; KUNSTLERIA; MEIZOTROPIS; PAPILIONOIDEAE; SPATHOLOBUS;

EID: 0030710212     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4382     Document Type: Article

References (41)

1. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
2. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
3. Duprez L, Parma J, Van Sande J, et al. 1994 Germline mutations in the thyrotropin receptor gene cause nonautoimmune autosomal dominant hyperthyroidism. Nat Genet. 7:396-401.
4. Tonacchera M, Van Sande J, Cetani F, et al. 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 81:547-554.
5. Fuehrer D, Willgerodt W, Scherbaum W, Paschke R. 1996 Identification of a new TSH receptor germline mutation as a cause of familial nonautoimmune hyperthyroidism [Abstract]. Thyroid. 6:60.
6. Köhler B, Biebermann H, Krohn HP, et al. 1996 A novel germline mutation in the thyrotropin receptor (TSHR) gene causing nonautoimmune congenital hyperthyroidism. Proc of the 10th International Congress of Endocrinology. 946:641 (Abstract).
7. Kopp P, Van Sande J, Parma J, et al. 1995 Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:150-154.
8. De Roux N, Polak M, Couet J, et al. 1996 A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab. 81:2023-2026.
9. Holzapfel HP, Wonerow P, Henschen M, et al. 1996 Congenital nonautoimmune hyperthyroidism caused by a new sporadic germline mutation in the thyrotropin receptor gene [Abstract]. J Endocrinol Invest. 19:25.
10. Esapa CT, Betts P, Kendall-Taylor P, Harris PE. 1996 A novel TSH receptor mutation in an infant with thyrotoxicosis [Abstract]. J Endocrinol Invest. 19:71.
11. Ledent C, Dumot JE, Vassart G, Parmentier M. 1992 Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J. 11:537-542.
12. 2+-cascades. Mol Endocrinol. 9:725-733.
13. Paschke R, Tonacchera M, Van Sande J, et al. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
14. Porcellini A, Ciullo I, Laviola L, et al. 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 79:657-661.
15. Russo D, Arturi F, Wicker R, et al. 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 80:1347-1351.
16. Russo D, Arturi F, Suarez HG, et al. 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1548-1551.
17. Duprez L, Parma J, Dumont JE, et al. 1996 Diversity and prevalence of somatic mutations in the TSH receptor gene as a cause of toxic adenoma [Abstract]. J Endocrinol Invest. 19:69.
18. O'Sullivan C, Barton CM, Staddon SL, et al. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:345-349.
19. Takeshita A, Nagayama Y, Yokoyama N, et al. 1995 Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab. 80:2607-2611.
20. Paschke R, Van Sande J, Parma J, Vassart G. 1996 The TSH receptor and thyroid disease. Baillieres Clin Endocrinol Metab. 10:9-28.
21. Baldwin JM. 1994 Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol. 6:180-190.
22. Spiegel AM. 1996 Genetic basis of endocrine disease. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab. 81:2434-2442.
23. Schipani E, Langman CB, Parfitt AM, et al. 1996 Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med. 335:708-714.
24. Prosser J. 1993 Detecting single-base mutations. TIBTECH. 11:238-246.
25. Suárez HG, Du Villard JA, Caillou B, et al. 1991 gsp mutations in human thyroid tumours. Oncogene. 6:677-679.
26. Russo D, Arturi F, Schlumberger M, et al. 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11:1907-1911.
27. De Roux N, Misrahi M, Chatelain N, et al. 1996 Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene. Mol Cell Endocrinol. 117:253-256.
28. Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. 1987 Isolation and characterization of the human Gs alpha gene. Proc Natl Acad Sci USA. 85:2081-2085.
29. Rosenthal A, Coutelle O, Craxton M. 1993 Large-scale production of DNA sequencing templates by microtitre format PCR. Nucleic Acids Res. 21:173-174.
30. Ausubel FM, Brent R, Kingston RE, et al. 1996 Current protocols in molecular biology. New York: Wiley Interscience.
31. Swillens S. 1995 Interpretation of binding curves with high receptor concentrations: practical aid for computer analysis. Mol Pharmacol. 47:1197-1203.
32. Munson PJ, Rodbard D. 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 107:220-239.
33. Kosugi S, Shenker A, Mori T. 1994 Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett. 356:291-294.
34. Gross B, Misrahi M, Sar S, Milgrom E. 1991 Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun. 177:679-687.
35. Reeve MA, Fuller CW. 1996 A novel thermostable polymerase for DNA sequencing. Nature. 376:796-797.
36. Maenhaut C, Roger PP, Reuse S, Dumont JE. 1991 Activation of the cyclic AMP cascade as an oncogenic mechanism: the thyroid example. Biochimie. 73:29-36.
37. Dumont JE, Lamy F, Roger PP, Maenhaut C. 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 72:667-697.
38. Cetani F, Tonacchera M, Vassart G. 1996 Different effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone chorionic gonadotropin receptors. FEBS Lett. 378:27-31.
39. Said S, Schlumberger M, Suárez HG. 1994 Oncogenes and anti-oncogenes in human epithelial thyroid tumors. J Endocrinol Invest. 17:317-379.
40. Van Sande J, Mockel J, Boeynaems JM, et al. 1988 Regulation of cyclic nucleotide and prostaglandin formation in normal human thyroid tissue and in autonomous nodules. J Clin Endocrinol Metab. 50:776-785.
41. Prévostel C, Alvaro V, de Boisvilliers F, et al. 1995 The natural protein kinase C mutant is present in human thyroid neoplasms. Oncogene. 11:669-674.